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Abstract
Objective The aim of this study was to evaluate a com-
plex association among intake of dietary vitamin D, cal-
cium, and retinol, and pancreatic cancer risk.
Methods Pancreatic cancer cases (n = 532) diagnosed in
1995–1999 were identified using rapid case ascertainment
methods and were frequency matched to population-based
controls (n = 1,701) in the San Francisco Bay Area.
Detailed dietary data were collected during in-person
interviews using a validated semi-quantitative food-
frequency questionnaire. Adjusted unconditional logistic
regression was used to estimate odds ratios (ORs) and
confidence intervals.
Results In men, increased pancreatic cancer risk was
associated with currently recommended dietary vitamin D
intake levels (highest (C450 IU/day) vs. lowest (\150 IU/
day) intake, OR = 2.6, trend-p = 0.009) and total vitamin
D intake from diet and supplements (for \800 IU/day).
ORs for dietary vitamin D intake remained increased after
adjustment for intake of retinol and calcium, although
confidence intervals included unity. Stratified analyses
showed that ORs were higher among men with lower
intake of retinol and lower physical activity but there was
no evidence of statistical interaction. No associations with
vitamin D intake were observed among women, although
ORs typically were elevated. ORs increased with increased
dietary calcium intake among men (trend-p = 0.008) and
not women.
Conclusions Our results among men showing an
increased risk of pancreatic cancer associated with dietary
intake of vitamin D and of calcium require confirmation in
further studies. Continued investigation is needed to clarify
the complex role of vitamin D and calcium in pancreatic
cancer risk and to determine their optimal intake level and
preventive effects for pancreatic cancer.
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Introduction
Recent medical advances have produced dramatic benefits
for some cancer patients, primarily by prolonging cancer-
free survival. However, 5-year survival rates for pancreatic
cancer patients remain at\5% [1]. Incidence and mortality
from pancreatic cancer have not abated in the United States
and continue to increase around the world, partly due to
few known modifiable risk factors and non-specific
symptoms that contribute to advanced-stage disease with
few treatment options at diagnosis [2]. Thus, development
of effective preventive strategies remains a priority.
Other than cigarette smoking, modifiable risk factors for
pancreatic cancer have not been consistently identified,
although obesity, heavy alcohol consumption and some
dietary factors have been reported [3, 4]. Dietary factors
that can be altered both by dietary changes and by use of
supplements have been a target of scientific investigation
but results from epidemiological studies have been incon-
sistent [3, 5, 6]. Vitamin D is of particular interest because
deficiency is associated with diabetes [7, 8], a suggested
risk factor for pancreatic cancer. In general, vitamin D
levels are influenced more by sun exposure than by diet [9],
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with fortified foods being a significant dietary source of
vitamin D in the US. Sun exposure has been linked with
lower cancer incidence and/or cancer mortality rates from
colon, breast, prostate and pancreatic cancer in ecological
studies [4, 10, 11]. In addition, epidemiological studies
consistently have showed significant associations between
low levels of vitamin D and increased age, obesity, and
African-American ethnicity, known risk factors of pan-
creatic cancer [12]. Because vitamin D also has been
shown to have anticarcinogenic properties in pancreatic
cancer cell lines [13], a strong hypothesis emerged that
high levels of vitamin D could be related to a reduced risk
of pancreatic cancer [6].
An initial report from a Finnish cohort study in male
smokers showed no association between dietary vitamin D
intake and pancreatic cancer [14], whereas analysis of two
large prospective cohorts in the United States showed that
increased dietary vitamin D was associated with a 30–40%
reduced risk of pancreatic cancer [10]. Additional analyses
of Finnish male smokers with low or moderate levels of
circulating metabolite 25-hydroxyvitamin D [25(OH)D],
considered a more accurate measure of total vitamin D
levels, showed increased risk of pancreatic cancer among
those with the highest 25(OH)D concentrations [15]. A
similar analysis of a US population with adequate or high
25(OH)D concentrations showed statistically non-signifi-
cant increased risks of a smaller magnitude [16]. A recently
published pooled analysis of eight cohort studies reported
a statistically significant increase in risk of pancreatic
cancer associated with a high 25(OH)D serum concentra-
tion [17].
In addition to sun exposure, vitamin D levels are affected
by the intake of other dietary nutrients, retinol and calcium.
Retinol is a known antagonist of vitamin D absorption [18],
whereas calcium requires vitamin D for its own intestinal
absorption and metabolism. At high levels, calcium regu-
lates the production of the active form of vitamin D [19].
Both nutrients are present in many multivitamin formula-
tions. Thus, to adequately assess the association between
vitamin D intake and pancreatic cancer risk, statistical
analyses need to evaluate the potential confounding or
effect modification related to intake of these nutrients.
To further explore the association between intake of
vitamin D (dietary and total intake consisting of diet and
supplements) and risk of pancreatic cancer, we analyzed
dietary data collected using a semi-quantitative food-fre-
quency questionnaire in our large population-based case–
control study of pancreatic cancer in the San Francisco Bay
Area. We also assessed the main effects of intake of vita-
min A, retinol, and calcium (dietary and total), and because
of their influence on vitamin D levels, their role as
confounders or modifiers of the association between
vitamin D and pancreatic cancer. Retinol (vitamin A) is a




Details of study methods and population characteristics
have been described previously [20–22]. Briefly, cases
were identified with incident adenocarcinoma of the exo-
crine pancreas diagnosed between 1995 and 1999 using
rapid case ascertainment. Eligible cases were 21–85 years
of age, residents of one of the six San Francisco Bay Area
counties, alive, and able to complete an in-person inter-
view in English. Pancreatic cancer diagnoses were con-
firmed by the participants’ physicians and by Surveillance,
Epidemiology and End Results (SEER) abstracts. A total
of 532 eligible patients completed the interview for a
response rate of 67%. Control participants were identified
by random digit dial supplemented by random sampling of
the Health Care Finance Administration (now Center for
Medicare and Medicaid Services) lists for those C65 years
old and were frequency matched to cases by sex, 5-year
age group, and county of residence. Eligibility criteria
were the same as for cases with the exception of their
pancreatic cancer diagnosis. A total of 1,701 eligible
controls completed the interview for a response rate of
67%.
Data collection
Extensive data were collected using a structured ques-
tionnaire administered by trained interviewers during in-
person interviews. Detailed data collected included age,
race, education, diabetes status, history of smoking, alcohol
consumption, physical activity, and anthropometric mea-
sures. Dietary history including use of vitamin and mineral
supplements was assessed using the 131-item semi-quan-
titative food-frequency questionnaire (FFQ) that has been
described in detail elsewhere [23] and has been validated in
a variety of populations [24–28]. Participants were asked to
report their average frequency of intake of specific foods
and associated portion size during 1 year before the diag-
nosis for cases or interview for controls. The scannable
questionnaires were processed by the Department of
Nutrition at the Harvard School of Public Health. Macro-
and micronutrient intake was computed by multiplying the
frequency of each food item by the nutrient content of the
standard portion size specified for each food item using
Harvard University’s food composition database that was
updated over time with data from the US Department of
Agriculture sources [29].
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No proxy interviews were conducted. The study proto-
cols were approved by the University of California San
Francisco Committee on Human Research. Written
informed consent was obtained from each participant prior
to interview.
Statistical methods
Standard chi-square methods were used to test the associ-
ation between categorical factors and pancreatic cancer.
Pearson’s correlation was used to measure a linear rela-
tionship between intakes of individual nutrients when
measured on a continuous scale. Odds ratios (ORs) and
95% confidence intervals (CIs) were computed using
multivariable unconditional logistic regression to estimate
the relative risk (hereafter called risk) of pancreatic cancer.
Tests for linear trend of the odds ratios were conducted by
modeling the median value for each category as a contin-
uous variable in multivariable logistic regression analyses.
All analyses were stratified by sex, and results are pre-
sented separately for women and men. Multivariable
models included age in 5-year groups, race (white, Black/
African American, Asian/Pacific Islanders, or ‘‘other’’),
total energy in quartiles, education level (less than high
school, high school, 1–4 years college, and graduate
school), usual adult body mass index (BMI: \25, 25 to
\30, and C30 kg/m2), smoking status (never smoker,
former cigarette smoker who quit smoking[15 years ago,
former cigarette smoker who quit smoking 1–15 years ago,
current cigarette smoker or smoker who quit within 1 year,
and pipe and/or cigar smoker), history of diabetes, fre-
quency of leisure time physical activity as an adult (30-min:
\1/month, 1–4/month, 2–3/week, and C4/week), and
alcohol consumption over the three decades prior to diag-
nosis/interview (never drinkers, B7, 8–14, 15–21, and[21
drinks/week). Analyses were conducted for nutrient intake
from food only, hereinafter referred to as ‘‘dietary’’ intake,
and for nutrient intake from food and from vitamin sup-
plements referred to as ‘‘total’’ intake. For comparability
with other studies [10], participants with intake of sup-
plements were excluded from analyses of the effects of
dietary intakes.
The residual method was used to analyze categorical
nutrient intake in models adjusted for total energy intake
[30]. Nutrient intake was categorized into four or five
groups based on the frequency distribution in the popula-
tion and on cutpoints used in previously published analyses
of these nutrients. Analyses stratified by smoking coded as
a dichotomous variable (non-smokers: never smokers,
former cigarette smokers who quit smoking[15 years ago,
and cigar and/or pipe smokers; smokers: cigarette smokers
who quit smoking 1–15 years ago, current cigarette
smokers or smokers who quit within 1 year) were
conducted to assess effect modification of smoking on the
association between vitamin D intake and pancreatic can-
cer. Likelihood ratio tests that compared models with and
without the smoking-nutrient cross-product term were used
to formally test for statistical interaction.
Statistical analyses were conducted using SAS software
V9.1 (SAS Institute, Inc., Cary, NC). All statistical tests
were 2-sided and considered statistically significant when
p \ 0.05.
Results
Descriptive characteristics of cases and controls are pre-
sented in Table 1. Relative to controls, a higher proportion
of cases were Black/African American, had fewer years of
education, and were current smokers. Compared with
controls, cases also were more likely to be in the highest
quartile of total energy intake (35 vs. 25%), to be over-
weight (37 vs. 32%), and to have been diagnosed with
diabetes (14 vs. 10%).
Vitamin D intake
In general, risk of pancreatic cancer increased with increased
intake of vitamin D from food only in men (Table 2). For
total vitamin D (food and supplement intake), risk increased
with increased intake until the highest category of intake
(C800 IU/day) where risk of pancreatic cancer was less than
unity and not different from those with the lowest intake
(\200 IU/day). Men with the highest dietary vitamin D
intake, without supplements (C450 IU/day), had a 2.6-fold
increased risk of pancreatic cancer compared with men with
the lowest intake (\150 IU dietary/day, trend-p = 0.009).
No statistically significant associations were observed
among women. When participants who took vitamin D
supplements were included in these analyses, dietary vitamin
D intake remained statistically significantly associated with
increased risk of pancreatic cancer (for highest vs. lowest
intake: Men: OR = 1.4, trend-p = 0.02; Women: OR =
1.1, trend-p = 0.09, data not shown). Dairy foods were the
major source of dietary vitamin D in our study population.
However, when models were adjusted for intake of dairy
foods, the increased risk of pancreatic cancer associated with
dietary vitamin D intake among men remained unchanged
(ORs = 1.6 (95% CI: 0.91–2.7), 1.9 (0.94–3.8), and 2.3
(0.88–5.8) for increasing categories of dietary vitamin D
intake, trend-p = 0.05).
Vitamin A and retinol
No associations were observed between pancreatic cancer
risk and intake of vitamin A in men or women (Table 3).
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An increased OR for the risk of pancreatic cancer was
observed among men and women with moderate levels of
dietary retinol intake, although individual ORs were not
different from unity and the OR was diminished among
those with the highest total retinol intake. In general, the
pattern of association with retinol was similar to that
observed with vitamin D, where CIs for individual ORs
were wide and included unity, and the magnitude of
the ORs for those with the highest intake was diminished
relative to the ORs for low to moderate intake.
Calcium
ORs for pancreatic cancer risk associated with total cal-
cium intake in men and women were slightly elevated,
although individual estimates were not different from unity
and the highest category of calcium intake was reduced in
women (trend-p = 0.94 men, and trend-p = 0.02 women).
Dietary calcium intake in food only was associated with an
increased risk of pancreatic cancer among men (highest vs.
lowest category, OR = 2.8, trend-p = 0.008, Table 3). In
contrast, no association was observed among women where
the pattern of results was similar to the non-linear effects
observed for vitamin D (ORs for highest intake were lower
than for low to moderate intake).
Associations and interactions among nutrients
Intake of total vitamin D was moderately correlated with
total intake of retinol (Pearson’s r = 0.65, p \ 0.0001) and
had moderately low correlations with total intake of vita-
min A (Pearson’s r = 0.45, p \ 0.0001) and total intake of
calcium (Pearson’s r = 0.38, p \ 0.0001) for men and
women combined. In sex-stratified analyses, the correlation
results for men and women separately were consistent with
those obtained in the combined analysis.
There was evidence in our data that vitamin D, calcium,
and retinol were mutual confounders. In models that also
included intake of calcium and retinol, pancreatic cancer
risk associated with total vitamin D intake among men was
unchanged, whereas risk associated with dietary intake
only was attenuated, and the trend in risk was no longer
statistically significant (highest vs. lowest intake: OR =
1.6, adjusted trend-p = 0.23, data not shown). In contrast,
the effects of total vitamin D intake in women were greater
after additional adjustment for total calcium and total ret-
inol intake and increased with increased total vitamin D
intake (highest vs. lowest intake: OR = 2.4, adjusted
trend-p = 0.05, data not shown). The association between
pancreatic cancer risk and dietary vitamin D intake in
women was unchanged in these expanded models.
No statistically significant interactions between vitamin
D intake and retinol were observed in our study population,
although some noteworthy variations in pancreatic cancer
risk were observed (Table 4). A nearly sixfold increased
risk of pancreatic cancer was observed among men with
[450 IU of dietary vitamin D and low dietary retinol
intake (interaction-p = 0.58, Table 4), and an eightfold
increased risk of pancreatic cancer was observed among
Table 1 Demographic, health, and lifestyle characteristics of cases
and controls in a population-based case–control study of pancreatic








\50 46 (9) 164 (10)
50–59 120 (22) 438 (26)
60–69 172 (32) 473 (28)
70–79 158 (30) 498 (29)
C80 36 (7) 128 (7)
Sex
Male 291 (55) 883 (52)
Female 241 (45) 818 (48)
Race
White 442 (83) 1471 (86)
Black/African American 46 (9) 78 (5)
Asian or Pacific Islander 35 (7) 119 (7)
Others 9 (2) 33 (2)
Education level
Less than high school 71 (13) 162 (10)
High school 164 (31) 372 (22)
1–4 years college 200 (38) 754 (44)
Graduate school 97 (18) 413 (24)
Diabetes
Yes 76 (14) 161 (10)
Body mass index (kg/m2)
\25 281 (53) 999 (59)
25 to \30 197 (37) 553 (32)
C30 54 (10) 149 (9)
Smoking
Non-smoker 163 (31) 652 (38)
Former smoker, quit [15 years 133 (25) 508 (30)
Former smoker, quit 1–15 years 89 (17) 260 (15)
Current smoker & quit \1 year 131 (25) 208 (12)
Pipe/cigar smoker 16 (3) 73 (4)
Total energy (kcal), quartiles (median)
Q1 (1,439) 103 (20) 425 (25)
Q2 (1,810) 112 (21) 425 (25)
Q3 (2,015) 124 (24) 425 (25)
Q4 (2,651) 186 (35) 426 (25)
a Numbers may not add up to the total number of participants because
of missing values
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women with[450 IU of dietary vitamin D and high dietary
retinol intake (interaction-p = 0.23, Table 4).
Smoking, physical activity, and vitamin D interactions
Among men, there was no evidence that smoking modified
the association between vitamin D intake and pancreatic
cancer risk (interaction-p = 0.40 for total vitamin D and
0.64 for dietary vitamin D intake, data not shown). In
contrast, among women, there was some weak evidence
that risk of pancreatic cancer associated with total vitamin
D intake was higher in non-smokers compared with
smokers (interaction-p = 0.12, data not shown). A similar
trend was observed for the intake of dietary vitamin D
among women.
In analyses stratified by low and high levels of physical
activity, ORs for dietary vitamin D that was associated
with pancreatic cancer risk were higher among men who
had a low physical activity level and higher in women who
had a high physical activity level. However, estimates were
imprecise, all confidence intervals included unity and there
was no evidence of statistical interaction (all interaction-
p [ 0.15, data not shown).
Discussion
In our large population-based case–control study, approx-
imately half of all study participants had adequate total
vitamin D intake according to current guidelines. Our
results provided support for increased risk of pancreatic
cancer with dietary vitamin D intake in men, although
increased risk associated with total vitamin D (vitamin
supplements and food) was limited to men with low to
Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for intake of vitamin D and risk of pancreatic cancer in a population-based case–










ORa, b 95% CI ORa, c 95% CI
Total vitamin D (diet and vitamin supplements), IU/day
Median, IU/day 376 351 414 448
\200 49 (17) 224 (25) 1 1 44 (19) 163 (20) 1 1
200–399 103 (36) 255 (29) 1.8 1.2, 2.7 2.0 1.4, 3.1 70 (30) 213 (26) 1.2 0.76, 1.8 1.5 0.96, 2.4
400–599 71 (25) 164 (19) 1.8 1.2, 2.8 2.2 1.4, 3.4 39 (16) 141 (17) 1.0 0.61, 1.7 1.1 0.66, 1.9
600–799 49 (17) 141 (16) 1.7 1.1, 2.7 2.2 1.4, 3.6 45 (19) 175 (21) 0.96 0.59, 1.5 1.2 0.71, 1.9
C800 16 (6) 99 (11) 0.81 0.43, 1.5 0.91 0.47, 1.7 39 (16) 126 (15) 1.1 0.69, 1.9 1.4 0.84, 2.4
Trend-p 0.95 0.45 0.93 0.64
Dietary vitamin D (from food only)d, IU/day
Median, IU/day 238 210 250 235
\ 150 29 (17) 119 (24) 1 1 21 (17) 72 (18) 1 1
150–299 91 (54) 255 (51) 1.4 0.87, 2.3 1.6 0.95, 2.6 59 (46) 198 (49) 1.0 0.58, 1.8 1.3 0.70, 2.6
300–449 37 (22) 93 (19) 1.7 0.97, 3.1 2.0 1.1, 3.8 38 (30) 97 (24) 1.3 0.70, 2.5 2.1 1.01, 4.2
C450 13 (8) 29 (6) 1.9 0.88, 4.3 2.6 1.1, 6.0 9 (7) 38 (9) 0.82 0.33, 2.0 0.93 0.35, 2.5
Trend-p 0.05 0.009 0.87 0.41
Vitamin D (from supplements only)e, IU/day
Median, IU/day
0 170 (59) 496 (56) 1 1 127 (54) 405 (50) 1 1
0, 400 12 (4) 50 (6) 0.75 0.38, 1.5 0.92 0.46, 1.9 10 (4) 57 (7) 0.56 0.28, 1.1 0.61 0.30, 1.3
400 92 (32) 279 (32) 0.97 0.72, 1.3 1.0 0.76, 1.4 85 (36) 295 (36) 0.91 0.66, 1.3 0.97 0.70, 1.4
[400 14 (5) 58 (7) 0.66 0.36, 1.2 0.71 0.38, 1.3 15 (6) 61 (7) 0.79 0.43, 1.5 0.82 0.44, 1.5
Trend-p 0.38 0.71 0.41 0.65
a Adjusted for energy intake by the residual method
b Adjusted for categories of age and total energy intake
c Additionally adjusted for body mass index, race, education, smoking, history of diabetes, physical activity, and alcohol consumption
d Excludes participants who had any specific nutrient supplement (multivitamin and single supplement)
e Includes participants with multivitamin and single supplement use
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Table 3 Odds ratios (ORs) and 95% confidence intervals (CIs) for intake of vitamin A, retinol, and calcium, and risk of pancreatic cancer in a










ORa, b 95% CI ORa, c 95% CI
Total vitamin A (diet and vitamin supplements), IU/day
Median, IU/day 11,945 12,729 14,999 16,284
\5,000 24 (8) 62 (7) 1.0 1.0 13 (6) 37 (5) 1.0 1.0
5,000–9,999 88 (31) 241 (27) 0.91 0.53, 1.6 1.0 0.58, 1.8 52 (22) 159 (19) 0.81 0.39, 1.7 1.0 0.49, 2.2
10,000–19,999 132 (46) 396 (45) 0.85 0.50, 1.4 1.1 0.61, 1.9 110 (46) 339 (41) 0.80 0.40, 1.6 1.1 0.52, 2.3
C20,000 44 (15) 184 (21) 0.62 0.34, 1.1 0.78 0.42, 1.5 62 (26) 283 (35) 0.54 0.26, 1.1 0.78 0.36, 1.7
Trend-p 0.05 0.22 0.01 0.12
Dietary vitamin A (from food only)d, IU/day
Median, IU/day 9,081 9,271 10,060 10,950
\5,000 25 (15) 59 (13) 1.0 1.0 10 (8) 38 (10) 1.0 1.0
5,000–9,999 74 (44) 198 (43) 0.88 0.50, 1.5 0.91 0.50, 1.6 51 (41) 130 (34) 1.5 0.67, 3.3 1.9 0.81, 4.6
10,000–19,999 58 (35) 170 (36) 0.82 0.46, 1.5 0.91 0.49, 1.7 49 (40) 149 (39) 1.2 0.56, 2.8 1.7 0.68, 4.1
C20,000 10 (6) 39 (8) 0.63 0.26, 1.5 0.68 0.27, 1.7 14 (11) 65 (17) 0.90 0.35, 2.3 1.2 0.44, 3.5
Trend-p 0.30 0.48 0.27 0.56
Total retinol (diet and vitamin supplements), IU/day
Median, IU/day 2,994 2,980 3,464 3,284
\2,000 107 (37) 368 (42) 1.0 1.0 88 (37) 303 (37) 1.0 1.0
2,000–3,999 70 (24) 172 (19) 1.4 1.0, 2.1 1.5 1.0, 2.1 57 (24) 157 (19) 1.2 0.83, 1.8 1.3 0.85, 1.9
4,000–7,999 87 (30) 244 (28) 1.3 0.91, 1.8 1.4 0.97, 1.9 65 (28) 244 (30) 0.92 0.63, 1.3 0.94 0.64, 1.4
C8,000 24 (8) 99 (11) 0.92 0.55, 1.5 0.93 0.55, 1.6 27 (11) 114 (14) 0.82 0.50, 1.3 0.92 0.55, 1.5
Trend-p 0.97 0.78 0.29 0.54
Dietary retinol (from food only)d, IU/day
Median, IU/day 1,493 1,274 1,417 1,418
\2,000 115 (67) 356 (73) 1.0 1.0 83 (63) 291 (72) 1.0 1.0
2,000–3,999 42 (25) 100 (20) 1.5 0.96, 2.3 1.6 1.0, 2.6 35 (27) 87 (21) 1.4 0.90, 2.3 1.3 0.78, 2.2
C4,000 14 (8) 34 (7) 1.6 0.79, 3.1 1.6 0.80, 3.3 13 (10) 29 (7) 1.7 0.81, 3.4 1.6 0.73, 3.4
Trend-p 0.06 0.04 0.07 0.17
Total calcium (diet and vitamin supplements), mg/day
Median, mg/day 726 714 887 1,051
\500 38 (13) 143 (16) 1.0 1.0 24 (10) 75 (9) 1.0 1.0
500–799 137 (48) 384 (43) 1.3 0.85, 2.0 1.4 0.88, 2.1 75 (32) 205 (25) 1.1 0.66, 1.9 1.3 0.75, 2.3
800–1,199 81 (28) 245 (28) 1.1 0.69, 1.7 1.2 0.73, 1.9 69 (29) 194 (24) 1.1 0.62, 1.8 1.5 0.82, 2.6
C1,200 32 (11) 111 (13) 1.0 0.58, 1.8 1.2 0.68, 2.1 69 (29) 344 (42) 0.61 0.36, 1.0 0.81 0.45, 1.4
Trend-p 0.5 0.94 0.001 0.02
Dietary calcium (from food only)d, mg/day
Median, mg/day 665 634 711 716
\500 38 (17) 143 (23) 1.0 1.0 22 (17) 62 (18) 1.0 1.0
500–799 123 (54) 340 (54) 1.3 0.88, 2.0 1.4 0.88, 2.2 64 (46) 168 (47) 1.1 0.61, 1.9 1.3 0.68, 2.4
800–1,199 52 (23) 125 (20) 1.5 0.90, 2.4 1.7 0.99, 2.8 42 (30) 86 (24) 1.3 0.71, 2.5 1.8 0.91, 3.7
C1,200 14 (6) 22 (3) 2.5 1.2, 5.6 2.8 1.2, 6.4 10 (7) 39 (11) 0.76 0.32, 1.8 0.70 0.27, 1.8
Trend-p 0.02 0.008 0.86 0.88
a Adjusted for energy intake by the residual method
b Adjusted for categories of age and total energy intake
c Additionally adjusted for body mass index, race, education, smoking, history of diabetes, physical activity, and alcohol consumption
d Excludes participants who had any specific nutrient supplement (multivitamin and single supplement)
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moderate levels of intake and was diminished in the highest
category of intake. The pattern of association between
calcium intake (total and dietary) and pancreatic cancer
risk was similar to that observed with vitamin D and again
was observed in men and not in women. In both men and
women, the association with calcium was confounded by
vitamin D intake. Vitamin A intake was not associated with
pancreatic cancer risk in men or women. Increased risks
were suggested for men and women with increased dietary
retinol intake, although results could have been due to
chance.
The Institute of Medicine’s (IOM) Food and Nutrition
Board currently recommends Dietary Reference Intake
(DRI) of total vitamin D at 400 IU/day for most adults and
600 IU/day for those [70 years of age. In our study,
median total vitamin D intake was adequate for those under
the age of 70 years (423 IU/day for men, 487 IU/day for
women), but not for those who were [70 years of age
(453 IU/day for men, 497 IU/day for women). We
observed that men with total vitamin D intake above the
DRI had lower risks than those in the lowest category of
intake. Recommendations recently have been published
advocating that the DRI be doubled [31] or be raised to
2,000 IU/day [32]. An expert panel of the IOM currently is
reviewing the official vitamin D recommendations that last
were updated in 1997. Final recommendations are expected
in 2010 [33].
Few population-based studies have investigated the
association between vitamin D and its analogs with pan-
creatic cancer risk, and their results have been inconsistent,
and overall, inconclusive. Similar to our findings, the
Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
(ATBC) among male Finnish smokers aged 50–69 years
reported a threefold significantly increased risk of pancre-
atic cancer among those with the highest serum concen-
trations of the vitamin D metabolite 25(OH)D [15] ([65.5
vs.\32.0 nmol/l). However, in the earlier analyses, dietary-
related vitamin D levels were not associated with risk [14].
The authors importantly noted that for the majority of the
Finnish study participants, vitamin D levels indicated
vitamin D deficiency (median dietary and total intake
4.9 mcg (196 IU/day) for cases and controls) and therefore
their results may be applicable to a vitamin D deficient
population only [14]. The largest to date pooled analysis of
Table 4 Odds ratios (ORs) and 95% confidence intervals (CIs) for risk of pancreatic cancer with the examination of interaction effects between
vitamin D intake and intake of retinol in a population-based case–control study, San Francisco Bay Area, California, 1995–1999
Total vitamin D (diet and vitamin supplements), IU/day Dietary vitamin D (from food only)b, IU/day
Categories Men Women Categories Men Women
ORa 95% CI ORa 95% CI ORa 95% CI ORa 95% CI
Retinol intake
Low total retinol intake Low dietary retinol intake
\2,980 IU/day \3,284 IU/day \1,274 IU/day \1,418 IU/day
\200 1 1 \150 1 1
200–399 2.1 1.3, 3.3 1.4 0.84, 2.5 150–299 1.3 0.66, 2.6 1.0 0.46, 2.2
400–599 2.4 1.2, 4.8 0.87 0.41, 1.9 300–449 1.5 0.46, 4.8 1.1 0.40, 3.3
600–799 NA 1.1 0.34, 3.2 C450 5.6 1.2, 26.4 0.2 0.02, 2.3
C800 NA 2.0 0.41, 9.9
Retinol intake
High total retinol intake High dietary retinol intake
C2,980 IU/day C3,284 IU/day C1,274 IU/day C1,418 IU/day
\200 1 1 \150 1 1
200–399 1.5 0.49, 4.6 2.4 0.61, 9.5 150–299 1.6 0.61, 4.2 9.6 1.3, 70.6
400–599 1.8 0.63, 5.4 1.6 0.43, 5.9 300–449 1.9 0.68, 5.4 21.6 2.7, 174.6
600–799 2 0.70, 5.9 1.5 0.41, 5.1 C450 1.9 0.53, 6.6 8.0 0.91, 70.0
C800 0.75 0.24, 2.4 1.9 0.52, 6.7
Interaction-p 0.19c 0.66 0.58 0.23
a Adjusted for energy intake by the residual method, categories of age, total energy intake, body mass index, race, education, smoking, history of
diabetes, physical activity, and alcohol consumption
b Excludes participants who had any specific nutrient supplement (multivitamin and single supplement)
c Due to small numbers of participants with total vitamin D intake C600 IU/day, the two upper categories were collapsed for the test of
statistical interaction between intake of total vitamin D intake and intake of total retinol
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eight cohort studies reported a statistically significant
twofold increase in the risk of pancreatic cancer associated
with a high 25(OH)D serum concentration (C100 vs.
50–75 nmol/l) [17].
These results contrast with those from a pooled analysis
of two cohort studies [10] and with a recent case–control
study nested within the Prostate, Lung, Colorectal, and
Ovarian (PLCO) screening trial [16]. Although the results
from the cohort studies showed a decreased risk with
increased vitamin D intake, similar to our results, the effect
appeared to be restricted to men [10]. The results from the
PLCO study are inconsistent with our and other’s results.
Investigators reported no association between serum
25(OH)D and pancreatic cancer in models adjusted for
time of year of blood draw (to account for a seasonal UVB
effect on vitamin D metabolite levels) [16]. The discrepant
results emphasize the complexity of a relationship between
vitamin D and pancreatic cancer risk that includes the
multiple methods that have been used by studies to deter-
mine a valid and informative measure of vitamin D status.
Vitamin D is a fat-soluble vitamin, and its concentration
depends upon supplements, dietary consumption of vitamin
D-rich foods and on endogenous production when ultra-
violet rays from sunlight strike the skin and trigger vitamin
D synthesis [34]. Studies based on reported dietary vitamin
D intake have a limited ability to account for solar-asso-
ciated skin production of vitamin D. This is further com-
plicated by known differences in individual ability to
synthesize vitamin D from the sun, including phenotypic
characteristics of the skin, i.e., melanin, age, geographic
longitude and latitude, seasonal variation, and personal sun
protection. Thus, accurate measurement of vitamin D
depends upon measuring concentrations of its metabolites.
One metabolite, 25-hydroxyvitamin D [35], is produced by
the liver and is affected by recent vitamin D intake. In
addition, the integral effects of vitamin A and retinol levels
(antagonists to vitamin D), calcium intake and absorption
(regulated by vitamin D and at high levels a regulator of
the production of the active form of vitamin D) [18], and
genetic variation in the expression of vitamin D receptors
need to be considered as they may confound or modify the
association between vitamin D levels and pancreatic cancer
risk. Our results combined with those of other published
studies emphasize a need to identify measures of dietary
and non-dietary effects on vitamin D status to gain a better
understanding of whether vitamin D may alter risk of
pancreatic cancer.
Intake of vitamin D supplements, retinol, and calcium
level of physical activity or smoking did not confound or
modify the association between dietary vitamin D intake
and risk of pancreatic cancer. Further, the increased risks
observed among men did not differ by high or low level of
dietary retinol, or by level of physical activity, although
ORs were slightly lower for higher physical activity levels
(2–3 times/week). In contrast, there was no clear pattern of
risks among women. The difference in risks between men
and women may be due to: differential sun exposure;
women’s higher percentage of body fat beyond that mea-
sured by body mass index [36]; or differences in dietary
and supplement-use patterns.
The strengths and weaknesses of case–control study
design and methods used to ascertain dietary intake should
be considered when interpreting the results from our study.
Information bias due to differential reporting of diet by
cases and controls is possible, although dietary risk factors
for pancreatic cancer are not firmly established nor widely
known in the community [5]. Therefore, it is less likely that
cases recalled their diet differently from controls, and our
response rates for cases and controls were similar. Overall
survival of our cases was not associated with vitamin D
intake among men and women (trend-p = 0.68 men, and
trend-p = 0.89 women, respectively), and the median time
from diagnosis to interview was less than 2 months. Thus,
although it is unlikely that our results were affected by
selection bias related to the rapid and high mortality among
pancreatic cancer cases, it is possible that our results per-
tain to ‘healthier’ pancreatic cancer patients.
Vitamin D levels also are affected by endogenous
vitamin D synthesis in the skin related to relatively short
exposure to ultraviolet rays from sunlight [6, 10]. Due to
rapid progression of pancreatic cancer, most cases are
unlikely to have experienced conditions or symptoms that
would greatly limit their activities for an extended period
of time before their pancreatic cancer diagnosis. Thus,
differentially lower sun exposure among cases is unlikely,
but the data regarding sun exposure were not available for
these analyses. It is more likely that age-related factors
would impact outdoor activity and sun-related vitamin D
production and our matching by age groups would help to
adjust for age-related effects.
The strengths of our study are many and include the
population-based design providing for comparability of
cases and controls on many measured and unmeasured
confounding variables. Case–control study design allowed
for greater power to test study hypotheses by including a
large number of population-based incident pancreatic
cancer cases identified from a cancer registry. The large
sample size provided adequate power to explore statistical
associations of interest and to explore confounding and
effect modification. Adequacy of the FFQ instrument has
been validated in multiple studies, both by re-testing study
participants using the same instrument and by comparing
nutrient intake from a food-frequency questionnaire with a
7-day recall diary [20, 21].
Our results suggesting that lower intake of dietary
vitamin D and dietary calcium may be associated with risk
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of pancreatic cancer in men require confirmation in inde-
pendent studies with careful assessment in the highest
categories of intake where risk was diminished. Continued
investigation in studies designed to assess multiple expo-
sures, and factors that affect vitamin D levels are warranted
to elucidate the non-linear associations with vitamin D and
calcium intake that were observed in our study population.
Few modifiable risk factors have been identified for pan-
creatic cancer. Data that can be used to determine an ideal
level of vitamin D intake and clarify the complex role of
vitamin D and calcium intake in pancreatic cancer risk may
be translated to prevention and intervention strategies for
this highly fatal cancer.
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